BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang MF, Wan B, Wu YL, Huang JF, Zhu YY, Li YB. Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection. World J Gastroenterol 2021; 27(4): 336-344 [PMID: 33584066 DOI: 10.3748/wjg.v27.i4.336]
URL: https://www.wjgnet.com/1007-9327/full/v27/i4/336.htm
Number Citing Articles
1
Haifeng Lv, Yanming Jiang, Geli Zhu, Shiyi Liu, Dian Wang, Jie Wang, Ke Zhao, Jing Liu. Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infectionScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-28351-3
2
Laurens A. van Kleef, Hannah S.J. Choi, Willem P. Brouwer, Bettina E. Hansen, Keyur Patel, Robert A. de Man, Harry L.A. Janssen, Robert J. de Knegt, Milan J. Sonneveld. Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis BJHEP Reports 2021; 3(5): 100350 doi: 10.1016/j.jhepr.2021.100350
3
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura. MAFLD enhances clinical practice for liver disease in the Asia-Pacific regionClinical and Molecular Hepatology 2022; 28(2): 150 doi: 10.3350/cmh.2021.0310
4
Giovanni Villa, Dorcas Owusu, Colette Smith, Marilyn Azumah, Adam Abdullahi, Suzannah Phillips, Laila Sayeed, Harrison Austin, David Chadwick, Richard Odame Phillips, Anna Maria Geretti. Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfectionHepatology Communications 2022; 6(11): 3036 doi: 10.1002/hep4.2000
5
Jiaofeng Huang, Wenjuan Xue, Mingfang Wang, Yinlian Wu, Medha Singh, Yueyong Zhu, Rahul Kumar, Su Lin. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant FibrosisDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3417 doi: 10.2147/DMSO.S316096
6
Ke-Gong Xiong, Kun-Yu Ke, Li-Fang Chen, Jin-Feng Kong, Tai-Shun Lin, Qing-Biao Lin, Su Lin, Yue-Yong Zhu. The impact of metabolic dysfunction–associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resectionHepatobiliary & Pancreatic Diseases International 2023; 22(4): 366 doi: 10.1016/j.hbpd.2022.04.001
7
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, Jingxuan Quek, Jie Ning Yong, Phoebe Tay, Darren Jun Hao Tan, Wen Hui Lim, Snow Yunni Lin, Daniel Huang, Mark Chan, Chin Meng Khoo, Nicholas W S Chew, Apichat Kaewdech, Naichaya Chamroonkul, Yock Young Dan, Mazen Noureddin, Mark Muthiah, Mohammed Eslam, Cheng Han Ng. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsThe Journal of Clinical Endocrinology & Metabolism 2022; 107(9): 2691 doi: 10.1210/clinem/dgac321
8
Yin-Lian Wu, Rahul Kumar, Ming-Fang Wang, Medha Singh, Jiao-Feng Huang, Yue-Yong Zhu, Su Lin. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver diseaseWorld Journal of Gastroenterology 2021; 27(34): 5753-5763 doi: 10.3748/wjg.v27.i34.5753
9
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen. Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in nameClinical and Molecular Hepatology 2022; 28(4): 790 doi: 10.3350/cmh.2022.0070
10
Yen-Po Lin, Shu-Hsien Lin, Chih-Chi Wang, Chih-Che Lin, Ding-Wei Chen, Ching-Hui Chuang, Pao-Yuan Huang, Chao-Hung Hung, Shih-Yu Yang, Wei-Ru Cho, Yu-Syuan Chen, Ming-Chao Tsai. Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative ResectionJournal of Personalized Medicine 2021; 11(8): 684 doi: 10.3390/jpm11080684
11
Danqing Hu, Peng Wang, Xiaojing Wang, Xue Hu, Da Huang, Weiming Yan, Dong Xi, Meifang Han, Qin Ning, Hongwu Wang. Disease severity and antiviral response in patients with chronic hepatitis B with non-obese NAFLDJournal of the Formosan Medical Association 2024; 123(7): 773 doi: 10.1016/j.jfma.2023.12.001
12
Zhao-Chun Chi. Progress in understanding of association between metabolic associated fatty liver disease and viral infectious diseasesWorld Chinese Journal of Digestology 2022; 30(18): 783 doi: 10.11569/wcjd.v30.i18.783
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
13
Shan Hong, Yiwei Hao, Lei Sun, Ping Li, Junru Yang, Fuyang Zhang, Lingling He, Jing Zhang, Hongshan Wei. Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver diseaseAnnals of Hepatology 2025; 30(2): 101589 doi: 10.1016/j.aohep.2024.101589
14
Lin Chen, Xuemei Tao, Minghui Zeng, Yuqin Li, Jiaxin Han, Yuekui Wang, Yonggang Liu, Ruifang Shi, Rui Su, Liang Xu, Yuqiang Mi. Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver diseaseJournal of Medical Virology 2024; 96(4) doi: 10.1002/jmv.29613
15
Yen-Po Lin, Pei-Ming Wang, Ching-Hui Chuang, Chee-Chen Yong, Yueh-Wei Liu, Pao-Yuan Huang, Chih-Chien Yao, Ming-Chao Tsai. Metabolic Risks Are Increasing in Non-B Non-C Early-Stage Hepatocellular Carcinoma: A 10-Year Follow-Up StudyFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.816472
16
Giovanni Villa, Dorcas Owusu, Marilyn Azumah, Adam Abdullahi, Suzannah Phillips, Laila Sayeed, Harrison Austin, David Chadwick, Richard Odame Phillips, Anna Maria Geretti. Liver Steatosis and Fibrosis in People Living With HIV in West Africa and Relationship With Highly Prevalent Hepatitis B Virus (HBV) Co-InfectionSSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3978563